Literature DB >> 1382793

Transurethral incision versus transurethral resection of the prostate. A subjective and objective analysis.

P F Soonawalla1, D S Pardanani.   

Abstract

A prospective study was undertaken comparing transurethral incision of the prostate (TUIP) with transurethral resection (TURP) in the treatment of 220 patients with urinary obstruction caused by a small, benign prostate. Patients were managed alternately by TUIP and TURP, and their symptoms and urodynamic findings evaluated before and after surgery. Subjectively and objectively, the results were comparable in both groups. Pre- and post-operative complications were significantly less for the TUIPs than the TURPs. TUIP was significantly better than TURP in terms of shorter operating time, duration of hospitalisation and reduced need for transfusion. We recommend TUIP as the operation of choice for the relief of obstruction in the presence of a small, benign prostatic enlargement.

Entities:  

Mesh:

Year:  1992        PMID: 1382793     DOI: 10.1111/j.1464-410x.1992.tb15698.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  4 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  A Melville; J Donovon; T Sheldon; T Peters
Journal:  Qual Health Care       Date:  1996-06

2.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 3.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 4.  The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials.

Authors:  Tania Lourenco; Matthew Shaw; Cynthia Fraser; Graeme MacLennan; James N'Dow; Robert Pickard
Journal:  World J Urol       Date:  2009-12-24       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.